Press release
Buccal Drug Delivery System Market Analysis 2024 -2033: Forecasted Market Size, Top Segments, And Largest Region | Teva Pharmaceuticals Industries Ltd., Pfizer Incorporated, GlaxoSmithKline Public Limited Company
Buccal Drug Delivery System Market Characteristics
The Business Research Company offers in-depth market insights through Buccal Drug Delivery System Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.
Market Size And Growth Forecast:
The buccal drug delivery system market size has grown rapidly in recent years. It will grow from $3.28 billion in 2023 to $3.64 billion in 2024 at a compound annual growth rate (CAGR) of 11.0%. The growth in the historic period can be attributed to early drug delivery innovations, pharmaceutical industry adoption, clinical studies and efficacy, market penetration strategies, disease-specific applications..
The buccal drug delivery system market size is expected to see rapid growth in the next few years. It will grow to $5.43 billion in 2028 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be attributed to patient-centric drug delivery, rising geriatric population, demand for targeted therapies, biologics and peptides delivery, regulatory support and approvals, investments in r&d. Major trends in the forecast period include patient convenience and compliance, advancements in drug formulations, rise in chronic diseases, pediatric and geriatric care, enhanced bioavailability..
Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=8290&type=smp
Market Segmentation:
The buccal drug delivery system market covered in this report is segmented -
1) By Type: Sublingual, Buccal Tablets and Lozenges, Oral Sprays
2) By Application: Pain Management, Smoking Cesstion, Angina Pectoris
3) By End-User: Hospitals, Ambulatory Centers, Other End-Users
Major Driver - Rising Chronic Diseases Drives The Buccal Drug Delivery Systems Market
The rising prevalence of chronic diseases is expected to propel the growth of the buccal drug delivery systems market going forward. Chronic diseases refer to ailments that persist for a year or longer, such as cancer, heart disease, stroke, diabetes, cancer, and arthritis. These are the most prevalent chronic illnesses that can be managed but not cured and necessitate continuous nutrition and medical care. Buccal drug delivery systems provide appropriate and effective drug delivery for administering mucosal and transmucosal drugs that are required by several patients suffering from chronic diseases such as diabetes and cancer. For instance, in September 2023, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations, there were 41 million deaths, which is 74% of those caused by non-communicable diseases (NCDs) or chronic diseases every year globally. There were 17.9 million deaths from cardiovascular diseases, 9.3 million deaths from cancer, 4.1 million deaths from chronic respiratory diseases, and 2.0 million deaths from diabetes. Therefore, the rising prevalence of chronic diseases drives the growth of the buccal drug delivery systems market .
Competitive Landscape:
Major companies operating in the buccal drug delivery system market report are Teva Pharmaceuticals Industries Ltd., Pfizer Incorporated, GlaxoSmithKline Public Limited Company, Indivior plc, Genere*x Biotechnology Corporation, Catalent Inc., Arx Limited Liability Company, BioDelivery Science International Incorporated, Cynapsus Therapeutics Incorporated, Endo Pharmaceuticals Public Limited Company, Medlab Clinical Ltd., AstraZeneca plc, F Hoffmann-La Roche Limited, Dr. Reddy's Laboratories Ltd., Takeda Pharmaceutical Company Limited, Novartis AG, Novo Nordisk A/S, Ethypharm SAS, Applied Pharma Research SA, Sunovion Pharmaceuticals Inc., Sanofi SA, Bayer AG, Adare Pharmaceuticals Inc., NAPP Pharmaceutical Ltd., Perrigo Company plc, Reckitt Benckiser Group plc, Teligent Pharma Inc., Par Pharmaceutical Companies Inc., Acorda Therapeutics Inc., Opiant Pharmaceuticals Inc.
Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/buccal-drug-delivery-system-global-market-report
Top Trend - Major Investments In Injectable Drug Delivery Systems Transforming The Buccal Drug Delivery Systems Market
Investments in injectable drug delivery systems are a key trend gaining popularity in the buccal drug delivery systems market. Major pharmaceutical companies are investing in drug delivery systems to sustain their position in the market. For instance, in September 2021, Novartis, a Switzerland-based pharmaceutical company, invested approximately $40 million in Credence MedSystems, a US-based company that develops innovative drug delivery systems. The aim of the investment is to boost the production of injectable drug delivery systems.
The Table Of Content For The Market Report Include:
1. Executive Summary
2. Buccal Drug Delivery System Market Characteristics
3. Buccal Drug Delivery System Market Trends And Strategies
4. Buccal Drug Delivery System Market - Macro Economic Scenario
5. Buccal Drug Delivery System Market Size And Growth
…..
27. Buccal Drug Delivery System Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx
About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Buccal Drug Delivery System Market Analysis 2024 -2033: Forecasted Market Size, Top Segments, And Largest Region | Teva Pharmaceuticals Industries Ltd., Pfizer Incorporated, GlaxoSmithKline Public Limited Company here
News-ID: 3418488 • Views: …
More Releases from The Business research company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Buccal
Top Trends Transforming the Buccal Cavity Devices Market Landscape in 2025: Tech …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Buccal Cavity Devices Industry Market Size Be by 2025?
In recent times, the market for buccal cavity devices has experienced significant expansion. Its growth is expected to rise from $2.26 billion in 2024 to $2.47 billion in 2025, registering a compound annual growth rate (CAGR) of…
Buccal Cavity Devices Market: Growth Dimensions, Key Players, and Market Trends …
Soaring Market Size of Buccal Cavity Devices: The Impact and Future Forecast
What Is The Projected Market Size Of The Global Buccal Cavity Devices Market And Its Growth Rate?
• The buccal cavity devices market grew strongly in recent years. It rose from $2.26 billion in 2024 to $2.47 billion in 2025, indicating a compound annual growth rate (CAGR) of 9.3%.
• The rise can be associated with advancements in oral drug delivery,…
Buccal Cavity Devices Market Report 2024 - Buccal Cavity Devices Market Growth, …
"The Business Research Company recently released a comprehensive report on the Global Buccal Cavity Devices Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The buccal cavity devices…
Dr. Anil Shah Introduces Revolutionary Micro Incision Technique for Buccal Fat R …
New York, NY - 22 October, 2024 - Dr. Anil Shah, an acclaimed facial plastic surgeon based in New York City, has developed a groundbreaking technique for buccal fat removal [https://www.nosesandnecksnyc.com/]that reduces scarring and recovery time. The innovative approach, known as the Micro Incision for Buccal Fat, involves creating an incision inside the mouth smaller than the size of a tooth. This advancement represents a significant breakthrough in buccal fat…
Buccal Tubes Market Will Generate Record Revenue by 2031
The Buccal Tubes Market size is expected to grow at an annual average of CAGR 6% during the forecast period (2024-2031). Buccal tubes are small, metal or ceramic orthodontic appliances that are bonded to the molars' buccal (cheek-facing) surfaces. These tubes are integral components of fixed orthodontic braces and serve as anchors for the braces' archwires, which help guide and align the teeth.
Buccal Tubes Market research report is one of…
Buccal Tubes Market Opportunities, Sales, Revenue, Gross Margin & Trends Analysi …
Buccal Tubes report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Buccal Tubes market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Demand from Hospital and Beauty Salon are the major drivers for the industry.
Global Buccal Tubes Market: Driven factors and Restrictions factors
The research…
